for the following products
1-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid | 4-(2-Hydroxypropan-2-yl)-2-propyl-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylic acid | Olmesartan | Olmesartan acid and Olmesartan Medoxomil EP Impurity A, RNH-6270
We are one of the world leading companies in manufacturing pharmaceutical standards, including stable-isotope labeled internal standards, metabolites, degradation compounds/impurities, and inhibitor reference compounds. Our products are widely used in Bioanalysis (BA) for preclinical/early stage clinical studies and Bioequivalence (BE) studies for generic drug development.
